Concepedia

Koichi Hasumi

KH

2

Publications

30

Citations

2

H-Index

1985

Active since

Affiliations

ASKA Pharmaceutical (Japan)(Current)

Koichi Hasumi is an author at ASKA Pharmaceutical (Japan) specializing in pharmacology, derivatives, and drug discovery.

Top concepts

PharmacologyMedicineChemistryDerivativesBiochemistryDrug DiscoveryDrug ResistancePharmacotherapyDrug DevelopmentNatural Sciences

Publications per year

1985–2014

2

Publications

2

Design and synthesis of 5-[(2-chloro-6-fluorophenyl)acetylamino]-3-(4-fluorophenyl)-4-(4-pyrimidinyl)isoxazole (AKP-001), a novel inhibitor of p38 MAP kinase with reduced side effects based on the antedrug concept

Koichi Hasumi, Shuichiro Sato, Takahisa Saito et al. · Bioorganic & Medicinal Chemistry · 2014 · 19 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Bioorganic Chemistry +14

Inverted prenylation of Nb-methoxycarbonyltryptamine. Synthesis of 3a-(1,1-dimethylallyl)pyrrolo(2,3-b)indole and 2-(1,1-dimethylallyl)tryptamine derivatives.

Tohru Hino, Koichi Hasumi, Hitoshi Yamaguchi et al. · Chemical and Pharmaceutical Bulletin · 1985 · 11 citations · Full text

Acid Treatment, Derivatives, Organic Chemistry +9

Rows per page

1–2 of 2